Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Randomized Crossover Trial
100%
Cognitive Function
100%
Hypoglycemia
80%
Plasma Glucose
80%
Psychomotor Speed
60%
Merck
40%
Hyperglycemic Clamp
40%
Global Cognition
40%
Counterregulatory Hormones
20%
Diabetes
20%
Group Assignment
20%
Fasting C-peptide
20%
Hyperinsulinemic
20%
Hyperinsulinemic-euglycemic Clamp
20%
Euglycaemia
20%
Neurocognitive Testing
20%
Non-severe
20%
Trial Registration
20%
Symbol Digit Modalities Test
20%
Outcome Test
20%
Executive Function
20%
Randomized Crossover Study
20%
Sustained Attention
20%
Sulfonylurea
20%
Glucose-lowering Drugs
20%
Hypoglycaemic Symptoms
20%
Alzheimer
20%
Cognitive Impairment
20%
Hyperinsulinemic Hypoglycemia
20%
Investigator-initiated Studies
20%
Verbal Memory
20%
Cognitive Score
20%
Cognitive Domains
20%
Insulin
20%
Hemoglobin A1c (HbA1c)
20%
Cognitive Performance
20%
Negative Impact
20%
Medicine and Dentistry
Hypoglycemia
100%
Maturity Onset Diabetes of the Young
100%
Cognition
100%
Antidiabetic Agent
42%
Counterregulatory Hormones
14%
Executive Function
14%
Hemoglobin A1c
14%
C-Peptide
14%
Sulfonylurea
14%
Body Mass Index
14%
Verbal Memory
14%
Symbol Digit Modalities Test
14%
Diabetes
14%
Glucose Clamp Technique
14%
Cognitive Defect
14%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
100%
Hypoglycemia
100%
Glucose Blood Level
57%
Antidiabetic Agent
42%
Cognitive Defect
14%
Hemoglobin A1c
14%
C Peptide
14%
Symbol Digit Modalities Test
14%
Glucose Clamp Technique
14%
Sulfonylurea
14%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoglycemia
100%
Non Insulin Dependent Diabetes Mellitus
100%
Antidiabetic Agent
42%
Hemoglobin A1c
14%
Sulfonylurea
14%
Cognitive Defect
14%
C Peptide
14%
Biochemistry, Genetics and Molecular Biology
Cognition
100%
Glucose Blood Level
80%
C-Peptide
20%
Sulfonylurea
20%
Executive Function
20%
Verbal Memory
20%
Food Science
Glucose Blood Level
100%
Insulin
50%